Unfair Competition

     LOS ANGELES – Hospira, International Medication Systems and American Regent are marketing an unapproved epinephrine-injection product that improperly competes with the Food and Drug Administration-approved Adrenalin, JHP Pharmaceuticals claims in Federal Court.

Exit mobile version